Current treatment options for allergic rhinitis: a review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232139Keywords:
AR, Intranasal corticosteroids, Antihistamines, ImmunotherapyAbstract
Allergic rhinitis (AR) is an immunoglobulin E-mediated inflammatory reaction in the nasal mucosa caused by inhaled allergens such as dust, pollen, mold, or animal dander. AR is a common chronic disease that is often ignored, misdiagnosed, and/or mistreated. Clinically, AR is characterized by four major symptoms such as rhinorrhea, sneezing, nasal itching, and nasal congestion. It can be associated with certain co-morbid conditions like asthma and nasal polyposis. AR is diagnosed by taking proper history taking, nasal examination, and allergy tests. A proper understanding of the pathophysiology of AR can lead to improved treatment of this disorder. The treatment for AR should target symptoms to improve the quality of life for patients. Undertreatment of AR often impairs quality of life. The important concern in the treatment of AR is the patient’s adherence to the treatment. Novel treatments are needed for cheaper, early, better, and more permanent symptom resolution in AR. Evidence-based guidelines for AR treatment are helpful to improve disease control. The treatment of AR includes avoidance of relevant allergens, appropriate pharmacotherapy, immunotherapy, patient education, and follow-up. Intranasal corticosteroids are the most effective modality of treatment for AR. This review article discusses details of current treatment options for AR.
Metrics
References
Swain SK, Behera IC, Das A, Mohanty JN. Normal saline nasal irrigation in childhood allergic rhinosinusitis: Our experiences in a tertiary care teaching hospital of Eastern India. Indian J Child Health. 2019;6(6):265-8.
Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105(5):917-22.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1-12.
Van Hoecke H, Vandenbulcke L, Van Cauwenberge P. Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update. Drugs .2007;67(18):2717-26.
Lagos JA, Marshall GD. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag. 2007;3(2):327-32.
Valk PJ, Simons M. Effects of loratadine/montelukast on vigilance and alertness task performance in a simulated cabin environment. Adv Ther. 2009;26(1):89-98.
Prasad R, Kumar R. Allergy situation in India: what is being done? Indian J Chest Dis Allied Sci. 2013;55:7-8.
Liu CM, Shun CT, Cheng YK. Soluble adhesion molecules and cytokines in perennial allergic rhinitis. Ann Allergy, Asthma Immunol. 1998;81(2):176-80.
Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63:1292-300.
Swain SK, Baliarsingh P. Sphenoid sinus mucocele: Our experiences at a tertiary care teaching hospital of Eastern India. Matrix Sci Medica. 2023;7(1):12-5.
Swain SK, Behera IC, Mohanty S, Sahu MC. Rhinogenic contact point headache-Frequently missed clinical entity. Apollo Med. 2016;13(3):169-73.
Swain SK, Sahu MC, Baisakh MR. Nasal myiasis in clinical practice. Apollo Med. 2018;15(3):128-31.
Small P, Frenkiel S, Becker A. Rhinitis: A practical and comprehensive approach to assessment and therapy. J Otolaryngol. 2007;36:5-27.
Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L et al. Efficacy of montelukast for treating perennial allergic rhinitis. Allergy Asthma Proc. 2007;28:296-304.
May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39:2410-9.
Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg. 2003;129:739-50.
Swain SK, Behera IC, Agrawala R, Shajahan N. Role of topical intranasal steroids in pediatric hearing loss due to otitis media with effusion: the experiences. Int J Otorhinolaryngol Head Neck Surg. 2020;6(1):89-93.
Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2):1-84.
Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S et al. BSACI guidelines for the management of allergic and non‐allergic rhinitis. Clin Experimental Allergy. 2008;38(1):19-42.
Meltzer EO. Intranasal steroids: managing allergic rhinitis and tailoring treatment to patient preference. Allergy Asthma Proc. 2005;26:445-51.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA). Allergy. 2008;63:8-160.
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(1):147-334.
Platt M. Pharmacotherapy for allergic rhinitis. Int Forum Allergy Rhinol. 2014;4(2):35-40.
Takhar P, Corrigan CJ, Smurthwaite L, O’Connor BJ, Durham SR, Lee TH et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol. 2007;119(1):213-8.
Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs. 2007;67(6):887-901.
Grainger J, Drake-Lee A. Montelukast in allergic rhinitis: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31(5):360-7.
Van Hoecke H, Vandenbulcke L, Van Cauwenberge P. Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update. Drugs. 2007;67(18):2717-26.
Rodrigo GJ, Yañez A. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol. 2006;96(6):779-86.
Li H, Sha Q, Zuo K, Jiang H, Cheng L, Shi J et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. Orl. 2009;71(1):50-5.
Swain SK, Sahu A. Steam inhalation as an adjuvant treatment in COVID-19 positive health care professionals: Our experiences at tertiary care teaching hospital. Int J Curr Res Rev. 2021;13(5):121-5.
GreinerAN, Hellings PW, Rotiroti G, Scadding GK. Allergicrhinitis. Lancet. 2011;378:2112-22.
Swain SK. Current treatment of Meniere's disease. Matrix Sci Medica. 2023;7(1):1-6.
Guvenc IA, Muluk NB, Mutlu FS, Eski E, Altıntoprak N, Oktemer T et al. Do probiotics have a role in the treatment of allergic rhinitis? A comprehensive systematic review and meta-analysis. Am J Rhinol Allergy. 2016; 30:157-75.
Lin WY, Fu LS, Lin HK, Shen CY, Chen YJ. Evaluation of the effect of Lactobacillus paracasei (HF. A00232) in children (6–13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo controlled study. Pediatr Neonatol. 2014;55:181-8.
Swain SK, Pattnaik T. Otorhinolaryngological manifestations in pregnant women. Medical Journal of Dr. DY Patil University. 2021;14(4):374-9.
Swain SK, Pattnaik T, Mohanty JN. Otological and rhinological manifestations in pregnancy: Our experiences at a tertiary care teaching hospital of East India. Int J Heal Allied Sci. 2020;9(2):159-63
Noble SL, Forbes RC, Woodbridge HB. Allergic rhinitis. Am Fam Physician. 1995;51(4):837-46.
Swain SK. Medical treatment of rhinitis in pregnant woman. Matrix Science Pharma. 2022;6(3):58-61.
Swain SK, Behera IC. Managing pediatric otorhinolaryngology patients in coronavirus disease-19 pandemic-A real challenge to the clinicians. Indian J Child Health. 2020;7(9):357-62.
Swain SK, Nahak B, Sahoo L, Munjal S, Sahu MC. Pediatric dysphonia-a review. Indian J Child Health. 2019;6(1):1-5.
Swain SK, Debta P, Samal S, Mohanty JN, Debta FM, Dani A. Endoscopic treatment of sinonasal ossifying fibroma: A case report. Indian J Public Health. 2019;10(09):1697-700.
Swain SK. Middle turbinate concha bullosa and its relationship with chronic sinusitis: A review. Int J Otorhinolaryngol Head Neck Surg. 2021;7(6):1062-67.
Swain SK, Baliarsingh P. Rhinogenic contact point headache in pediatric age group: A review. Int J Contemp Pediatr. 2022; 9:135-9.